150+
Clinical studies completed in metabolic diseases
100+
Clinical trial sites strategically located worldwide
24,800+
Study participants enrolled early phase in clinical trials
Specialized expertise to accelerate obesity drug development
Experience trusted by patients, sites, and study teams
Our services are initiated from deep scientific expertise in disease pathophysiology, drug classes, methodologies, patient engagement, and two decades of experience in clinical research, development, and regulatory strategies exclusively for metabolic diseases, including a wealth of experience with obesity targets and respective study designs.
Accelerating study start-up
Our specialized study start-up team and Hub & Spokes™ platform is a game-changer, ensuring streamlined country and site selection, improved enrollment, and accelerated study launch – providing a dramatic and positive impact on the timelines and the conduct of the entire clinical study.
data-driven, patient-centric recruitment strategies
Our data-driven, proactive recruitment strategies ensure that our clinical trials are enrolling eligible patients at the most qualified sites and engaging with the study participants throughout the study and beyond to promote retention and a positive experience.
